Interchange Capital Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Interchange Capital Partners's AMGN Position: Q2 2026 in Review
Interchange Capital Partners increased its Amgen (AMGN) stake by 29% in Q2 2026, buying an estimated $163K and bringing the position to 2,111 shares worth $765K. The position accounts for 0.14% of the portfolio, ranked #143.
Interchange Capital Partners first reported a position in AMGN in Q4 2020 and has held it in 21 quarters since. The position peaked at $880K in Q1 2023. 3,149 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Interchange Capital Partners held 2,111 shares of Amgen worth $765K as of Q2 2026.
- Interchange Capital Partners bought 475 Amgen shares in Q2 2026, an estimated $163K.
- Amgen made up 0.14% of Interchange Capital Partners's portfolio in Q2 2026, its #143 holding.
- Interchange Capital Partners first reported a position in Amgen in Q4 2020 and has held it in 21 quarters since.
- Interchange Capital Partners's Amgen position peaked at $880K in Q1 2023.
- 3,149 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Interchange Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.